637 related articles for article (PubMed ID: 10828869)
1. Introduction of the oncological pediatric risk of mortality score (O-PRISM) for ICU support following stem cell transplantation in children.
Schneider DT; Lemburg P; Sprock I; Heying R; Göbel U; Nürnberger W
Bone Marrow Transplant; 2000 May; 25(10):1079-86. PubMed ID: 10828869
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in children requiring admission to an intensive care unit after hematopoietic stem cell transplant.
Cheuk DK; Ha SY; Lee SL; Chan GC; Tsoi NS; Lau YL
Hematol Oncol; 2004 Mar; 22(1):1-9. PubMed ID: 15152366
[TBL] [Abstract][Full Text] [Related]
3. Serial evaluation of the oncological pediatric risk of mortality (O-PRISM) score following allogeneic bone marrow transplantation in children.
Schneider DT; Cho J; Laws HJ; Dilloo D; Göbel U; Nürnberger W
Bone Marrow Transplant; 2002 Mar; 29(5):383-9. PubMed ID: 11919727
[TBL] [Abstract][Full Text] [Related]
4. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation.
Diaz MA; Vicent MG; Prudencio M; Rodriguez F; Marin C; Serrano A; Sevilla J; Casado J; Madero L
Haematologica; 2002 Mar; 87(3):292-8. PubMed ID: 11869942
[TBL] [Abstract][Full Text] [Related]
5. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports.
Pène F; Aubron C; Azoulay E; Blot F; Thiéry G; Raynard B; Schlemmer B; Nitenberg G; Buzyn A; Arnaud P; Socié G; Mira JP
J Clin Oncol; 2006 Feb; 24(4):643-9. PubMed ID: 16380411
[TBL] [Abstract][Full Text] [Related]
6. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
7. Outcome of children requiring admission to an intensive care unit after bone marrow transplantation.
Jacobe SJ; Hassan A; Veys P; Mok Q
Crit Care Med; 2003 May; 31(5):1299-305. PubMed ID: 12771594
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
[TBL] [Abstract][Full Text] [Related]
9. The sepsis-related Organ Failure Assessment (SOFA) score is predictive for survival of patients admitted to the intensive care unit following allogeneic blood stem cell transplantation.
Neumann F; Lobitz O; Fenk R; Bruns I; Köstering M; Steiner S; Hennersdorf M; Kelm M; Strauer BE; Germing U; Hinke A; Haas R; Kobbe G
Ann Hematol; 2008 Apr; 87(4):299-304. PubMed ID: 18219487
[TBL] [Abstract][Full Text] [Related]
10. Changing outcomes for children requiring intensive care following hematopoietic stem cell transplantation.
Kache S; Weiss IK; Moore TB
Pediatr Transplant; 2006 May; 10(3):299-303. PubMed ID: 16677352
[TBL] [Abstract][Full Text] [Related]
11. Role of the intensive care unit in children undergoing bone marrow transplantation with life-threatening complications.
Díaz de Heredia C; Moreno A; Olivé T; Iglesias J; Ortega JJ
Bone Marrow Transplant; 1999 Jul; 24(2):163-8. PubMed ID: 10455344
[TBL] [Abstract][Full Text] [Related]
12. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
13. Early elevation of C-reactive protein correlates with severe infection and nonrelapse mortality in children undergoing allogeneic stem cell transplantation.
McNeer JL; Kletzel M; Rademaker A; Alford K; O'Day K; Schaefer C; Duerst R; Jacobsohn DA
Biol Blood Marrow Transplant; 2010 Mar; 16(3):350-7. PubMed ID: 20005964
[TBL] [Abstract][Full Text] [Related]
14. Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors.
Jackson SR; Tweeddale MG; Barnett MJ; Spinelli JJ; Sutherland HJ; Reece DE; Klingemann HG; Nantel SH; Fung HC; Toze CL; Phillips GL; Shepherd JD
Bone Marrow Transplant; 1998 Apr; 21(7):697-704. PubMed ID: 9578310
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of acute physiology and chronic health evaluation (APACHE) II and III score-based screening in patients receiving allogeneic hematopoietic stem-cell transplantation.
Kim SW; Kami M; Urahama N; Yamamoto R; Hori A; Imataki O; Kanda Y; Tanosaki R; Mineishi S; Takaue Y; Honda O
Transplantation; 2003 Feb; 75(4):566-70. PubMed ID: 12605131
[TBL] [Abstract][Full Text] [Related]
16. Survival in a recent cohort of mechanically ventilated pediatric allogeneic hematopoietic stem cell transplantation recipients.
van Gestel JP; Bollen CW; Bierings MB; Boelens JJ; Wulffraat NM; van Vught AJ
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1385-93. PubMed ID: 19041061
[TBL] [Abstract][Full Text] [Related]
17. Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipients.
Schmid I; Stachel D; Pagel P; Albert MH
Biol Blood Marrow Transplant; 2008 Apr; 14(4):438-44. PubMed ID: 18342786
[TBL] [Abstract][Full Text] [Related]
18. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
[TBL] [Abstract][Full Text] [Related]
19. Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients.
Afessa B; Tefferi A; Dunn WF; Litzow MR; Peters SG
Crit Care Med; 2003 Jun; 31(6):1715-21. PubMed ID: 12794410
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RIC.
Barba P; Piñana JL; Martino R; Valcárcel D; Amorós A; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2010 Mar; 16(3):413-20. PubMed ID: 19922807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
